venetoclax
abbvie,roche
['leusm', 'aml,(-streamline),(-seamless),(-kamloops),(-latamleaders),(-dreamlike)', 'venetoclax']
#ash22 #leusm weng: more data re genetic assoc w response to hma/ven in rr aml needed to help predict outcomes. broad range of reported resp rates (21-67%) in rr setting can be found in the literature. n=139 w genetic data and who were treated with hma/ven in china studied here. 
Assoc Professor, UCSF hematology/BMT. Translational researcher interested in leukemia, MDS, MRD, post-HCT relapse, GVHD, & immune recon. Photos: pyknosis (IG)